Diabetes type 2

BRIGHT publication

The RESTORE-G Real World Evidence Study

RESTORE-G: Real-world analysis in insulin-naïve adults with T2D on GLP-1 RA ± OAD(s), intensifying their therapy by starting basal insulin and discontinuing GLP-1 RA, or adding basal insulin to ongoing GLP-1 RA, or initiating a FRC product and discontinuing current GLP-1 RA†2

Switching from other basal insulins to Toujeo® (Insulin Glargine)

Is het tijd voor insulinetherapie?

Ondersteunende materialen voor mensen met diabetes

Download hier handig de verschillende voorlichtingsmaterialen op het gebied van diabetes.

American Diabetes Association: 83rd Scientific Sessions

Selection of the Key Topics

Video Prof. Snoek Diabetes & Mental Health

In deze video vertelt Prof. Snoek over de relatie tussen het hebben van Diabetes en de mentale gezondheid van de diabetespatiënt. Dit doet hij door middel van resultaten uit studies en onderzoeken.

Mental Health Webinar

In deze webinar van 1 uur spreken prof. dr. Frank Snoek, dr. Ileana Pina en dr. Torild Skrivarhaug over de mentale impact van diabetes. De moderator van de webinar is dr. Manuel Castro Cabezas. De webinar is in het Engels.

The Deliver-G study

DELIVER-G: Real-world analysis in insulin-naïve adults with T2DM on GLP-1 RA ± OAD(s), intensifying their therapy by starting basal insulin and discontinuing GLP-1 RA, or adding basal insulin to ongoing GLP-1 RA, or initiating a FRC product and discontinuing current GLP-1 RA†¹

Personalized approach in T2D is key for success

The Sanofi webinar ‘Act Now for Impact: Glycemic Control and Beyond’ focuses on recent advancements in treating type 2 diabetes (T2D), emphasizing a personalized approach for better outcomes. Prof. Frank Nobels (Belgium), prof. De Galan (the Netherlands) and Prof Björn Eliasson (Sweden) addressed various aspects of T2D treatment in the present era.

42 factoren